Analgesics in France

Analgesics in France

  • September 2016
  • 28 pages
  • Euromonitor International
Report ID: 198051
Acetaminophen which offered greater convenience to consumers started to emerge in the country at the end of the review period. During the first half of 2015, for instance, Laboratoires UPSA launched three versions of Efferalgan for administration directly onto the tongue, without water. At the end of 2015 Sanofi also invested in this new format, with the launch of several references for adults and children who prefer products which do not need to be taken with water. These were important drivers...

Euromonitor International’s Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

ANALGESICS IN FRANCE
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2011-2016
Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Johnson & Johnson Santé Beauté France SA in Consumer Health (france)
Strategic Direction
Key Facts
Summary 1 Johnson & Johnson Santé Beauté France SA: Key Facts
Summary 2 Johnson & Johnson Santé Beauté France SA: Operational Indicators
Competitive Positioning
Summary 3 Johnson & Johnson Santé Beauté France SA: Competitive Position 2016
Laboratoires Urgo Sas in Consumer Health (france)
Strategic Direction
Key Facts
Summary 4 Laboratoires URGO SAS: Key Facts
Summary 5 Laboratoires URGO SAS: Operational Indicators
Competitive Positioning
Summary 6 Laboratoires URGO SAS: Competitive Position 2016
Executive Summary
Better Performance Compared With the Review Period
Manufacturers Invest in Medical Devices and New OTC Ranges of Rx Brands
Specialisation Strategies Are the Winners in 2016
Chemists/pharmacies Sees Increasing Competition From Internet Retailing
Flat Value Growth Over the Forecast Period
Key Trends and Developments
Medical Devices - An Increasingly Common Status in Consumer Health
Rx Umbrella Brands Give Quick Recognition To Consumer Health Products
the Evolution of Internet Retailing Is Inhibited by the Law Forbidding Sales of OTC Medicines
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 7 OTC: Switches 2014-2016
Definitions
Sources
Summary 8 Research Sources












Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.

Country=France Industry=OTC ParentIndustry=Pharmaceutical Date=201609 Topic=MarketReport Publisher=EuromonitorInternational Price=1000